Emig U, Meyer T, Buchwald A B
Medizinische Klinik, Georg-August-Universität Göttingen.
Dtsch Med Wochenschr. 1997 Aug 1;122(31-32):965-8. doi: 10.1055/s-2008-1047716.
After 10 days of intravenous heparin treatment of a 25-year-old woman with recurrent pulmonary emboli, thrombocytopenia occurred with a platelet drop from 1.52 x 10(5)/microliter to 3.6 x 10(4)/microliter. Heparin-induced platelet activation assays confirmed the diagnosis of heparin-induced thrombocytopenia (HIT). The detected heparin-dependent antibodies exhibited in vitro cross-reactivity with low-molecular-weight heparins, but not with danaparoid.
After heparin was stopped and platelet counts were normal, a massive thrombosis of the iliofemoral veins and the inferior vena cava occurred. Under protection of a temporary vena cava filter, systemic anticoagulation with danaparoid (anti-factor Xa-activity 0.4-0.8 U/ml) and transcatheter thrombolysis with urokinase (70,000 U/h) was initiated. Within 8 days of treatment a complete recanalisation of the occluded iliofemoral and caval veins was achieved. Oral anticoagulation with phenprocoumon was started and the patient has since then been free of symptoms.
The case demonstrates successful treatment of massive iliofemoral and caval thrombosis in the HIT syndrome achieved by combined transcatheter administration of urokinase and systemic infusion of danaparoid.
一名25岁复发性肺栓塞女性接受了10天的静脉肝素治疗后,出现血小板减少,血小板计数从1.52×10⁵/微升降至3.6×10⁴/微升。肝素诱导的血小板活化试验确诊为肝素诱导的血小板减少症(HIT)。检测到的肝素依赖性抗体在体外与低分子量肝素具有交叉反应性,但与达那肝素无交叉反应。
停用肝素且血小板计数恢复正常后,患者发生了髂股静脉和下腔静脉的大面积血栓形成。在临时下腔静脉滤器的保护下,开始使用达那肝素(抗Xa因子活性0.4 - 0.8 U/ml)进行全身抗凝,并使用尿激酶(70,000 U/h)进行经导管溶栓治疗。治疗8天内,闭塞的髂股静脉和腔静脉实现了完全再通。开始使用苯丙香豆素进行口服抗凝治疗,此后患者无症状。
该病例表明,通过联合经导管给予尿激酶和全身输注达那肝素,成功治疗了HIT综合征中的大面积髂股静脉和腔静脉血栓形成。